Z. Yigit Et Al. , "The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation," JAPANESE HEART JOURNAL , vol.44, no.3, pp.369-377, 2003
Yigit, Z. Et Al. 2003. The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation. JAPANESE HEART JOURNAL , vol.44, no.3 , 369-377.
Yigit, Z., Kucukoglu, M., Okcun, B., Sansoy, V., & Guzelsoy, D., (2003). The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation. JAPANESE HEART JOURNAL , vol.44, no.3, 369-377.
Yigit, Z Et Al. "The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation," JAPANESE HEART JOURNAL , vol.44, no.3, 369-377, 2003
Yigit, Z Et Al. "The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation." JAPANESE HEART JOURNAL , vol.44, no.3, pp.369-377, 2003
Yigit, Z. Et Al. (2003) . "The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation." JAPANESE HEART JOURNAL , vol.44, no.3, pp.369-377.
@article{article, author={Z Yigit Et Al. }, title={The safety of low-molecular weight heparins for the prevention of thromboembolic events after cardioversion of atrial fibrillation}, journal={JAPANESE HEART JOURNAL}, year=2003, pages={369-377} }